Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
6.87
-0.10 (-1.43%)
Mar 4, 2026, 3:42 PM EST - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.25 billion as of March 4, 2026. Its market cap has decreased by -60.70% in one year.
Market Cap
2.25B
Enterprise Value
2.59B
1-Year Change
-60.70%
Ranking
Category
Stock Price
$6.87
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.25B, an increase of 1,853.57%. That is a compound annual growth rate of 43.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.35B | -7.26% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.56B |
| Adaptive Biotechnologies | 2.47B |
| Immunome | 2.45B |
| Dianthus Therapeutics | 2.40B |
| Ocular Therapeutix | 2.33B |
| Mineralys Therapeutics | 2.31B |
| Galapagos NV | 2.23B |
| Ultragenyx Pharmaceutical | 2.20B |